USPTO serial 99647697
DEAGE
Reviewed by CopyMark Law Group
Status 688Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- FLOWERS, JAY K
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with DEAGE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $349*
Plus Government fees of $150
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Andrew D. Bochner
Andrew D. Bochner Bochner PLLC1040 Avenue of the Americas, 15th FloorNew York, NY 10018United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of Sepsis, Septic Shock, bacterial skin and tissue Infections, fungal skin and tissue Infections, viral skin and tissue Infections, parasitic skin and tissue infections, Pneumonia, Acute Respiratory Distress Syndrome, Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity, Osteoarthritis, osteoarthritis of the knee, osteoarthritis of the hip, osteoarthritis of the shoulder, other osteoarthroses, degenerative disc disease, namely, intervertebral disc degeneration, Alzheimer’s disease; Pharmaceutical preparations for the treatment of Parkinson’s disease, Neonatal Stroke, Neonatal Sepsis, Intraventricular Hemorrhage, Ischemic Stroke, Hemorrhagic Stroke, Perioperative Myocardial Infarction, heart failure, chronic kidney disease, Chronic Obstructive Pulmonary Disease (COPD), idiopathic pulmonary fibrosis, diabetic foot ulcers, type 1 diabetes mellitus, Graft versus Host Disease (GvHD), rheumatoid arthritis, ankylosing spondylitis, multiple sclerosis, psoriasis, perianal fistulas associated with Crohn’s disease; Medicinal preparations for the treatment of Sepsis, Septic Shock, bacterial skin and tissue Infections, fungal skin and tissue Infections, viral skin and tissue Infections, parasitic skin and tissue infections, Pneumonia, Acute Respiratory Distress Syndrome, Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity, Osteoarthritis, osteoarthritis of the knee, osteoarthritis of the hip, osteoarthritis of the shoulder, other osteoarthroses; Medicinal preparations for degenerative disc disease, namely, intervertebral disc degeneration, Alzheimer’s disease, Parkinson’s disease, Neonatal Stroke, Neonatal Sepsis, Intraventricular Hemorrhage, Ischemic Stroke, Hemorrhagic Stroke, Perioperative Myocardial Infarction, heart failure, chronic kidney disease; Medicinal preparations for Chronic Obstructive Pulmonary Disease (COPD), idiopathic pulmonary fibrosis, diabetic foot ulcers, type 1 diabetes mellitus, Graft versus Host Disease (GvHD), rheumatoid arthritis, ankylosing spondylitis, multiple sclerosis, psoriasis, perianal fistulas associated with Crohn’s disease | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 1, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 7, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 7, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 1, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 9, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 5, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 11, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 11, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 11, 2026 | NWAP | NEW APPLICATION ENTERED | — |